This comprehensive SOP establishes procedures for receiving and evaluating all compounding components (APIs, prescription products, OTC products) including visual inspection protocols, transaction data verification, certificate of analysis review, quarantine procedures, and suspect/illegitimate product identification and reporting requirements to ensure supply chain integrity and patient safety under DSCSA compliance.